Doximity, Inc. DOCS
We are the leading physician-first tech company, with over 3 million registered members1 as of March 31, 2026. 10-K, Item 1
- Headquarters
- San Francisco, CA
- CEO
- Jeffrey Tangney
- Next results
- around Feb 4, 2027
Where each dollar of revenue went, FY2026
Revenue of $644.9M through the costs to a net profit of $196.1M · income statement of the 10-K
DOCS among Technology peers
Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.
What changed
22 new risk paragraphs. 10-K filed May 19, 2026 against May 20, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
10 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 10 checks found nothing to note
-
Receivables +12.8% ($128.4M to $144.8M) vs revenue +13.1% ($570.4M to $644.9M), -0.3 pts apart
-
Cash from operations $326.5M vs net income $196.1M (FY ending Mar 31, 2026)
-
Same auditor in both 10-Ks: Deloitte & Touche LLP
7 more checks with nothing to note
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Revenue Recognition - Subscriptions; REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
22 paragraphs in Risk Factors that were not in the 10-K filed May 20, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed May 20, 2025 10-K, ITEM 1A
Our investments in AI may not achieve the expected benefits and may expose us to additional risks.
-
Item 1A · new paragraph · not in the 10-K filed May 20, 2025 10-K, ITEM 1A
In addition, laws, regulations, enforcement priorities and industry standards relating to AI, automated decision-making, privacy, data security, transparency and consumer protection are evolving and could increase our compliance costs or require changes to our products, services or business practices.
-
Item 1A · new paragraph · not in the 10-K filed May 20, 2025 10-K, ITEM 1A
Our development, deployment, and use of artificial intelligence may not achieve the expected benefits and may create operational, reputational, competitive, regulatory, legal, and liability risks. We use artificial intelligence, machine learning, generative AI, and other AI-enabled technologies as part of operating our business, and we…
-
Item 1A · new paragraph · not in the 10-K filed May 20, 2025 10-K, ITEM 1A
We rely on software-as-a-service, or SaaS, and AI technologies from third parties.
New risk paragraphs, against peers
Latest 10-K of each, Technology companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Revenue | $419.1M | $475.4M | $570.4M | $644.9M |
| Net income | $112.8M | $147.6M | $223.2M | $196.1M |
| Operating cash flow | $179.6M | $184.1M | $273.3M | $326.5M |
| Free cash flow | $177.9M | $183.9M | $273.3M | $326.5M |
Revenue, FY2020 to FY2026
Ten fiscal years, each from its own 10-K · XBRL · USD
$644.9M ▲ 13.1% in FY2026$196.1M ▼ 12.2% in FY2026$326.5M ▲ 19.5% in FY2026
Recent filings
6 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 5, 2026TIMOTHY STEPHEN CABRAL (Director) gave notice of a planned sale of 10,721 shares worth about $375K Form 144, approximate sale date Nov 5, 2026, under a 10b5-1 plan adopted Feb 19, 2026
-
Planned saleNov 5, 2026John Vaughan (General Counsel of the Company) adopted a 10b5-1 trading plan reported in the 10-Q, runs to Jun 1, 2027
-
Planned saleNov 5, 2026Matthew Sonefeldt (Chief Financial Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 17,644 shares, runs to Aug 31, 2027
-
8-KNov 5, 2026Quarterly results 8-K item 2.02
-
10-QNov 5, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Doximity, Inc., San Francisco, CA · from the 10-K filed May 19, 2026
We are the leading physician-first tech company, with over 3 million registered members1 as of March 31, 2026. Our registered members represent more than 85% of U.S. physicians, spanning all 50 states and every medical specialty, along with two-thirds of U.S. nurse practitioners and physician assistants, and approximately 90% of graduating U.S. medical students. We calculate U.S. physicians as all U.S. physicians (MDs/DOs) who are under the age of 76, not retired, hold an active medical license, and have a physician status on the National Provider Identifier (NPI) registry. As of March 31, 2026, the total number of U.S. physicians was approximately 1 million.
- Headquarters
- San Francisco, CA
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- March 31
- Last results
- Nov 5, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed May 19, 2026 (open at SEC), compared with the 10-K filed May 20, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DOCS/export.csv") into a cell.